This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Innovations of Alexander J Reif
Introduction
Alexander J Reif is a notable inventor based in Holland, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological and psychiatric disorders. With a total of 3 patents, his work has the potential to impact the treatment of various diseases associated with glutamate dysfunction.
Latest Patents
One of his latest patents involves imidazopyridin-2-one derivatives. This invention is directed to compounds that act as potentiators of metabotropic glutamate receptors, specifically the mGluR receptor. These compounds are useful in the treatment or prevention of neurological and psychiatric disorders linked to glutamate dysfunction. Additionally, the invention includes pharmaceutical compositions that utilize these compounds for therapeutic purposes.
Another significant patent by Reif focuses on positive allosteric modulators of the mGluR2 receptor. This invention encompasses benzimidazolone derivatives that serve as positive allosteric modulators, which are beneficial in treating or preventing neurological and psychiatric disorders associated with glutamate dysfunction. The patent also covers pharmaceutical compositions that incorporate these compounds for the prevention or treatment of diseases such as schizophrenia.
Career Highlights
Alexander J Reif is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in pharmaceutical development.
Collaborations
Some of his notable coworkers include Mark E Layton and Joseph E Pero. Their collaborative efforts have further advanced the research and development of compounds aimed at addressing critical health issues.
Conclusion
Alexander J Reif's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving treatments for neurological and psychiatric disorders. His work continues to pave the way for advancements in medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile